Home › Core › ISCC-IDs › 28CrYtE4QUJJX

View ISCC-ID

Core Data

28CrYtE4QUJJX
ISCC-ID - digital asset identifier
CCjLV8gmsNtmS-CTXaWcFqzU7zR-CDL7LdGcsqWH8-CRiQwB5tfVm1T
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

axl knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasi

Ledger Reference

coblo
Source Ledger/Blockchain
220304
N-th ISCC Decleration on source ledger
147bf59d1dd5aa37a5e8b4ad0cd93cfc0c1261712f4d24ce99b3ec8c68c9c427
Hash of block that includes the ISCC-DECLARATION
94dc3c0488ecf04e4ea5ce413a78db0bc3bcbb117c54f59e802a59d0d64d3479
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=26725&path%5B%5D=84770", "encodingFormat": "application/pdf"}], "publisher": {"name": "Impact Journals, LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.18632/oncotarget.26725", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjLV8gmsNtmS-CTXaWcFqzU7zR-CDL7LdGcsqWH8-CRiQwB5tfVm1T", "propertyID": "ISCC"}], "datePublished": "2019-02-19"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close